|
|
| | GSK2141795 Basic information |
| Product Name: | GSK2141795 | | Synonyms: | GSK2141795;Uprosertib;Uprosertib(GSK2141795);Uprosertib , GSK2141795C;GSK 2141795C;N-[(1S)-2-Amino-1-[(3,4-difluorophenyl)methyl]ethyl]-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-furancarboxamide;2-Furancarboxamide, N-[(1S)-2-amino-1-[(3,4-difluorophenyl)methyl]ethyl]-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-;GSK795 | | CAS: | 1047634-65-0 | | MF: | C18H16Cl2F2N4O2 | | MW: | 429.25 | | EINECS: | | | Product Categories: | API | | Mol File: | 1047634-65-0.mol |  |
| | GSK2141795 Chemical Properties |
| storage temp. | Store at -20°C | | solubility | DMSO:45.33(Max Conc. mg/mL);105.6(Max Conc. mM)
DMF:1.0(Max Conc. mg/mL);2.33(Max Conc. mM)
Ethanol:85.0(Max Conc. mg/mL);198.02(Max Conc. mM) | | form | Powder |
| | GSK2141795 Usage And Synthesis |
| Uses | Uprosertib is a potent and selective inhibitor of pan-Akt (1). Serine/threonine protein kinases, such as Akt, play important roles in cellular activities including cell survival and apoptosis. |
| | GSK2141795 Preparation Products And Raw materials |
|